These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35967135)

  • 1. Comparison of Dosimetric Parameters in Dysphagia Aspiration-Related Structures and Clinical Correlation in Head and Neck Cancer Patients Treated With Radiotherapy.
    Upadhyay P; Kumar P; Chauhan AK; Kumar P; Nigam J; S N
    Cureus; 2022 Jul; 14(7):e26765. PubMed ID: 35967135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Achieving Dose Constraints for Dysphagia Aspiration-Related Structures and Its Clinical Significance in Intensity-Modulated Radiotherapy Planning of Head and Neck Cancer.
    Agarwal K; Kumar P; S N; Kumar P; Garg A; Nigam J; N S S
    Cureus; 2024 Feb; 16(2):e53769. PubMed ID: 38465172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Radiation on Dysphagia-Related Structures: A Dosimetric and Clinical Comparative Analysis of Three-Dimensional Conformal Radiotherapy (3D-CRT) and Intensity-Modulated Radiation Therapy (IMRT) Techniques in Patients With Head and Neck Cancer.
    Manam S; Teja R; Pb AR; Azharuddin SK
    Cureus; 2024 Apr; 16(4):e58276. PubMed ID: 38752101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
    Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
    Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
    BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dose to dysphagia aspiration-related structures and its effect on swallowing: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy plans.
    Prameela CG; Ravind R; Renil Mon PS; Sheejamol VS; Dinesh M
    J Cancer Res Ther; 2016; 12(2):845-51. PubMed ID: 27461662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
    Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
    Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
    Hedström J; Tuomi L; Finizia C; Olsson C
    Clin Transl Radiat Oncol; 2019 Nov; 19():87-95. PubMed ID: 31646203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can dysphagia aspiration related structures (DARS) be spared in patients with oropharyngeal cancers? Dosimetric evaluation in a prospective study of DARS optimized intensity modulated radiation therapy.
    Calcuttawala A; Shinghal A; Budrukkar AN; Swain M; Murthy V; Laskar SG; Gupta T; Upereti R; Kale S; Agarwal JP
    J Cancer Res Ther; 2024 Jul; 20(5):1499-1506. PubMed ID: 39412914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Dosimetric Parameters and Clinical Outcomes in Inversely Planned Intensity-Modulated Radiotherapy (IMRT) and Field-in-Field Forward Planned IMRT for the Treatment of Breast Cancer.
    Azharuddin SK; Kumar P; S N; Chauhan AK; Kumar P; Nigam J; Mehta A
    Cureus; 2022 Jul; 14(7):e26692. PubMed ID: 35949741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
    Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicities and clinical outcome of adjuvant dysphagia optimized versus standard intensity-modulated radiotherapy for post-operative oral cavity cancers: A prospective comparative study.
    Patni A; Rastogi M; Gandhi AK; Mishra VK; Srivastava AK; Sharma V; Agarwal A; Khurana R; Hadi R; Sapru S; Mishra SP
    Head Neck; 2023 Dec; 45(12):3119-3128. PubMed ID: 37814926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?
    Petkar I; Bhide S; Newbold K; Harrington K; Nutting C
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):e110-e118. PubMed ID: 28242166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity Profile of IMRT Vs. 3D-CRT in Head and Neck Cancer: A Retrospective Study.
    Ghosh G; Tallari R; Malviya A
    J Clin Diagn Res; 2016 Sep; 10(9):XC01-XC03. PubMed ID: 27790562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial.
    Ashour MG; Shouman TH; Hassouna AH; Mokhtar MH; Emad El Din R; Youssef AA; Gomaa MM; Abdelgeleel S
    Acta Oncol; 2022 Feb; 61(2):134-140. PubMed ID: 35000532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.